Rhys Williams

Publications and Insights

• Publication: Immunoglobulin sustainability in the United Kingdom
• Publication: The economic burden of overweight and obesity in Europe
• Insight: Around the World in HTAs: Zimbabwe – Seizing a window of opportunity
• Publication: Unlocking the broader value of biologic therapies through biosimilar-enabled access and repositioning 
• Publication: The value of cell and gene therapies to the UK economy
• Insight: Around the World in HTAs: Saudi Arabia – Navigating the healthcare and HTA landscape
• Insight: Around the World in HTAs: Kenya – Riding the Waves of Change
• Publication: Challenges and Solutions for Budget Impact Analysis of Gene Therapies
• Insight: Advancing Rare Disease Care: Challenges and Key Issues
• Publication: The Importance of Diversity of Supply in Rare Diseases Markets
• Publication: The Cost of Drug Shortages
• Insight: Drug shortages are on the rise – but what is their impact?
• Publication: A Framework for Value-aligned Pricing of Combination Therapies
• Insight: Using Target Product Profiles (TPPs) to improve diagnostic testing for cancer
• Publication: The Socioeconomic Burden Of Cervical Cancer in the UK: What are the benefits of achieving the WHO elimination target?
• Publication: The Dynamics of Drug Shortages
• Publication: Reimagining Prevention for a Healthier, More Prosperous Society
• Publication: Are Recommendations for HTA of Gene Therapies Being Achieved?
• Publication: Economic Aspects of Non-Hodgkin’s Lymphoma
• Publication: Diabetes: a Model for Health Care Management